Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Malaria

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Smallpox

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Early Perturbations in Red Blood Cells in Response to Murine Malarial Parasite Infection: Proof-of-Concept <sup>1</sup>H NMR Metabolomic Study.

Life (Basel, Switzerland)·2023

Same author

Corrigendum to article "Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies" [Int. J. Pharm. 431(1-2) (2012) 149-160].

International journal of pharmaceutics·2022

Same author

A history of juvenile mild malaria exacerbates chronic stress-evoked anxiety-like behavior, neuroinflammation, and decline of adult hippocampal neurogenesis in mice.

Journal of neuroimmunology·2020

Same author

Molecular study of binding of Plasmodium ribosomal protein P2 to erythrocytes.

Biochimie·2020

Same author

Early Perturbations in Glucose Utilization in Malaria-Infected Murine Erythrocytes, Liver and Brain Observed by Metabolomics.

Metabolites·2020

Same author

Vivax infection alters peripheral B-cell profile and induces persistent serum IgM.

Parasite immunology·2018

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Malaria vaccine: a current perspective.

Shobhona Sharma¹, Sulabha Pathak

¹Department of Biological Sciences, Tata Institute of Fundamental Research, Mumbai, India. sharma@tifr.res.in

Journal of Vector Borne Diseases

|April 11, 2008

Summary

This summary is machine-generated.

Despite a century of research, an effective malaria vaccine remains elusive. Current efforts focus on understanding immune responses and evaluating new antigen combinations in clinical trials.

More Related Videos

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

Related Experiment Videos

Last Updated: Jul 6, 2026

Generating Genetically Modified Plasmodium berghei Sporozoites

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

Area of Science:

Malariology
Vaccinology
Immunology

Background:

The concept of malaria protection via inactivated Plasmodium sporozoites dates back a century.
Systematic studies with irradiated sporozoites in the 1960s spurred malaria vaccine development.
Cloning of the circumsporozoite protein (CSP) in 1983 raised hopes for a CSP-based vaccine.

Purpose of the Study:

To review the current status of malaria vaccine development.
To discuss the challenges hindering the creation of an effective malaria vaccine.
To explore the poor understanding of host-immune responses in malaria-immune individuals.

Main Methods:

Review of recent scientific literature on malaria vaccine research.
Analysis of ongoing clinical trials evaluating antigen and adjuvant combinations.
Discussion of genomic and proteomic data of malaria parasites.

Main Results:

Despite extensive research, an effective malaria vaccine is still unavailable.
Clinical immunity in endemic areas is documented, but underlying immune mechanisms are poorly understood.
Several vaccine candidates are in clinical trials assessing efficacy against sporozoite challenge and natural infection.

Conclusions:

Significant knowledge gaps in host-immune responses impede malaria vaccine development.
Overcoming unresolved challenges is crucial for achieving effective malaria control through vaccination.
Continued research into parasite genomics, proteomics, and host immunity is essential.